Skip to main content

ETF comparison

XBI vs XLV

Both Healthcare.

State Street SPDR S&P Biotech ETF · State Street Health Care Select Sector SPDR ETF

Holdings overlap

Weighted by ISIN/CUSIP
6.3 %

8 positions appear in both funds. Buying equal dollars of XBI and XLV would leave roughly 6.3% of each dollar exposed to the same underlying securities.

XBI unmatched 93.6% Shared 6.3% XLV unmatched 93.4%

Unmatched is the part of a fund's weight the other fund doesn't match: names only it holds, plus any extra weight it puts in names both funds hold.

In XBI only
148 positions
Shared
8 positions
In XLV only
52 positions

Side by side

XBI

State Street SPDR S&P Biotech ETF

State Street · Healthcare

82 composite / 100
Expense ratio
0.35%
Net assets
$10.36B
TTM yield
0.36%
Top-10 conc.
13.3%
XLV

State Street Health Care Select Sector SPDR ETF

State Street · Healthcare

82 composite / 100
Expense ratio
0.080%
Net assets
$43.39B
TTM yield
1.42%
Top-10 conc.
61.5%

Sub-score comparison

65
Cost
92
85
Tax efficiency
83
100
Liquidity
100
95
Concentration
26
—
Tracking quality
—
XBI sub-score XLV

Tracking quality isn't part of the composite — see what we don't score for why.

Cost difference

XLV is 27 bps cheaper than XBI. On a $100,000 position that's about $270/yr more in fees for XBI.

Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open the cost calculator pre-filled with XBI vs XLV.

Top shared holdings

8 shared in total
# Holding In XBI In XLV Overlap
1 Vertex Pharmaceuticals Inc 1.06% 2.19% 1.06%
2 AbbVie Inc 1.04% 7.74% 1.04%
3 Amgen Inc 0.99% 3.40% 0.99%
4 Gilead Sciences Inc 0.96% 2.73% 0.96%
5 Regeneron Pharmaceuticals Inc 0.96% 1.08% 0.96%
6 Biogen Inc 1.03% 0.56% 0.56%
7 Moderna Inc 1.41% 0.43% 0.43%
8 Incyte Corp 1.00% 0.33% 0.33%

Only in XBI

148 total
  • Apogee Therapeutics Inc 1.49%
  • Twist Bioscience Corp 1.41%
  • Oruka Therapeutics Inc 1.38%
  • Kymera Therapeutics Inc 1.36%
  • Viking Therapeutics Inc 1.30%
  • Praxis Precision Medicines Inc 1.29%
  • Erasca Inc 1.27%
  • Revolution Medicines Inc 1.20%
  • Rhythm Pharmaceuticals Inc 1.20%
  • CG oncology Inc 1.20%

Only in XLV

52 total
  • Eli Lilly & Co 16.51%
  • Johnson & Johnson 10.64%
  • UnitedHealth Group Inc 6.57%
  • Merck & Co Inc 5.52%
  • Thermo Fisher Scientific Inc 3.24%
  • Abbott Laboratories 2.75%
  • Intuitive Surgical Inc 2.45%
  • Pfizer Inc 2.39%
  • CVS Health Corp 2.30%
  • Danaher Corp 2.09%

Percentages are holdings overlap with the named fund.

Open XBI or XLV at a brokerage

Both funds trade commission-free at major US brokerages.

Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.